Healthcare

Can the healthcare industry really expect to drive patient engagement?

Can the healthcare industry really expect to drive patient engagement?

Increasing patient engagement as a tool for improving care and outcomes has been a tough code to crack for the healthcare industry.

The MM&M buyer's guide to boutique consulting services

The MM&M buyer's guide to boutique consulting services

You've seen what the biggies can do. What about the smaller end of the spectrum? MM&M's second buyer's guide to pharma, healthcare, and life sciences consulting services focuses on the dos and don'ts of hiring boutique firms.

Omnicom Health's CEO on agency consolidation and why Japan's healthcare market is a 'bellwether'

Omnicom Health's CEO on agency consolidation and why Japan's healthcare market is a 'bellwether'

By

The healthcare marketing group made another major acquisition in the country last month.

Omnicom beats estimates in Q1, but sees slight dip in North America

Omnicom beats estimates in Q1, but sees slight dip in North America

Omnicom's healthcare revenue was up 2.7% in Q1

What's the state of diversity in healthcare agencies?

What's the state of diversity in healthcare agencies?

By

The 2018 MM&M/Publicis Health Diversity Survey is open.

APCO hires Nancy Turett as healthcare executive director

APCO hires Nancy Turett as healthcare executive director

By

Turett spent 25 years at Edelman before launching her own firm in 2013.

Dr. Reddy's Laboratories CEO of developed markets Alok Sonig makes Wall Street listen

Dr. Reddy's Laboratories CEO of developed markets Alok Sonig makes Wall Street listen

By

Alok Sonig, chief executive officer of developed markets at Dr. Reddy's Laboratories, articulates the benefits of generics.

Standing out in the era of value-based healthcare marketing

Standing out in the era of value-based healthcare marketing

With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

By

Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?

DTC ads 2017: The good, the bad, and the ugly

DTC ads 2017: The good, the bad, and the ugly

By

We considered pharma and healthcare ads that, per iSpotTV, started airing no earlier than January 2017.

MM&M unveils its Hall of Femme and Women to Watch 2018

MM&M unveils its Hall of Femme and Women to Watch 2018

MM&M is honoring 16 of the most-senior women in the healthcare industry along with 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.

HealthSpark 2018 unites disruptors at SXSW

HealthSpark 2018 unites disruptors at SXSW

AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed

Infographic | AI's impact on patients and caregivers

Infographic | AI's impact on patients and caregivers

By

Caregivers and patients predict how the use of AI will affect them.

 Five things for pharma marketers to know: Friday, March 30, 2018

Five things for pharma marketers to know: Friday, March 30, 2018

By

Walmart and Humana have started acquisition talks; Blue Cross and Blue Shield says opioids should not be the first treatment option to manage pain

The Cambridge Analytica mess: What does it mean for pharma?

The Cambridge Analytica mess: What does it mean for pharma?

What happens in the world of Facebook cannot be ignored in pharma marketing. It increasingly lives in a world of data that is highly sensitive and must be managed well.

Five things for pharma marketers to know: Thursday, March 29, 2018

Five things for pharma marketers to know: Thursday, March 29, 2018

PhRMA has released a series of new ads that blame high drug prices on cost increases to insurers and PBMs; Veterans Affairs Secretary Dr. David Shulkin has been fired; UK biotech Redx has suspended a Phase I/II trial of its cancer drug

CDM New York's Chris Palmer on 5 a.m. wake-ups, Reddit, and what he's reading

CDM New York's Chris Palmer on 5 a.m. wake-ups, Reddit, and what he's reading

Chris Palmer, president of CDM New York, shares his wake-up routine, what he's reading and his dream of owning a record store if he wasn't in the medical marketing field.

Will the real patient advocate please stand up?

Will the real patient advocate please stand up?

By

Industry opponents say the end is nigh for pharma's ability to deduct expenses for consumer drug advertising, but those who've found their calling in healthcare comms ought to have something to say about that.

Rbb Communications forms Healthcare Advisory Council

Rbb Communications forms Healthcare Advisory Council

By

The council, made up of seasoned pharma execs, will function as consultants to rbb's health clients and health team.

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

By

The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.

 MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

By

MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.

Infographic | Highlighting top healthcare trends

Infographic | Highlighting top healthcare trends

By

There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy to lose sight of everything else. PwC's Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.

Payers: High-deductible health plans don't drive positive consumer behavior

Payers: High-deductible health plans don't drive positive consumer behavior

By

As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.

How should pharma mine electronic health records as a data source?

How should pharma mine electronic health records as a data source?

By

At a time when value-based healthcare is a more common objective among stakeholders, EHR data can enable collaboration among payers, providers, health systems, and pharma manufacturers.

Five things for pharma marketers to know: Monday, February 5

Five things for pharma marketers to know: Monday, February 5

By

Opdivo hits key goal in late-stage trial; Philippines government sues Sanofi over anti-dengue vaccine; hospitals reach capacity amid record flu season.

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

By

Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.

The race is on: Amazon, Buffett, and JPMorgan enter healthcare

The race is on: Amazon, Buffett, and JPMorgan enter healthcare

Forget making incremental changes to the system. These three corporate giants are trying to change the model of U.S. healthcare itself.

Five things for pharma marketers to know: Tuesday, January 30, 2018

Five things for pharma marketers to know: Tuesday, January 30, 2018

By

Amazon, Berkshire Hathaway, and JPMorgan team up to form a healthcare company; Takeda's Zika vaccine receives FDA fast-track status

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

By

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Five things for pharma marketers to know: Friday, January 5, 2018

Five things for pharma marketers to know: Friday, January 5, 2018

By

Takeda announces deals worth more than $1 billion; biotech and pharma investments reached $10.5 billion in 2017; prescriptions for nerve pain on the rise